Join to View Full Profile
1441 Avocado AveSte 301Newport Beach, CA 92660
Phone+1 949-272-2095
Fax+1 949-272-2096
Dr. Harb is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1996 - 1998- Indiana University School of MedicineResidency, Internal Medicine, 1993 - 1996
Damascus University Faculty of MedicineClass of 1992
Certifications & Licensure
CA State Medical License 2021 - 2027
MI State Medical License 2018 - 2023
IN State Medical License 1996 - 2021
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc, 2015, 2017
- CMS Meaningful Use Stage 2 Certification OncoEMR by Flatiron Health, Flatiron Health, Inc., 2015, 2017
- CMS Meaningful Use Stage 2 Certification OncoEMR by Flatiron Health, Flatiron Health, Inc., 2015, 2017
Clinical Trials
- Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer Start of enrollment: 2008 Jan 01
- BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
- PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations
Publications & Presentations
PubMed
- 8 citationsResults from phase 1 of the MANIFEST clinical trial to evaluate the safety and tolerability of pelabresib in patients with myeloid malignancies.Eytan M Stein, Amir T Fathi, Wael A Harb, Gozde Colak, Andrea Fusco
Leukemia & Lymphoma. 2024-04-01 - 20 citationsFirst-in-human phase I dose escalation trial of the first-in-class tumor microenvironment modulator VT1021 in advanced solid tumors.Devalingam Mahalingam, Wael Harb, Amita Patnaik, Andrea Bullock, Randolph S Watnick
Communications Medicine. 2024-01-13 - 31 citationsSafety and efficacy of the tumor-selective adenovirus enadenotucirev, in combination with nivolumab, in patients with advanced/metastatic epithelial cancer: a phase I ...Marwan Fakih, Wael Harb, Daruka Mahadevan, Hani Babiker, Jordan Berlin
Journal for Immunotherapy of Cancer. 2023-04-01
Press Mentions
3 Ways Vitamin D May Boost Longevity, According to ResearchNovember 16th, 2025- Experimental Drug Eliminates Aggressive Breast, Skin Cancer in Small TrialAugust 16th, 2025
- Certain Type of Statins May Help Decrease Liver Cancer RiskMarch 26th, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
